TechPat: Monsanto Loses Third Glyphosate Jury Verdict; Fourth Trial Set in Missouri Today

patent Tech Patents technology

Monsanto Corp., the Big Ag company which manufactures the weed killer ROUNDUP®, and was the loser in three California jury trials which $2.48 billion in potential damages, in which all the plaintiffs asserted the active ingredient in ROUNDUP, glyphosate, caused their non-Hodgkin’s lymphoma (NHL), is getting ready for a fourth trial, this time in its …

Continue Reading

CannabIP: U.S. Patent No. PP30,434 P3

Cannabis IP patent plantIP

U.S. Patent No. PP30,434 P3 (‘434) issued on April 23, 2019, for “Cannabis Plant Named ‘LW-BB1’.”  It was issued to inventors Andrew Alfred, Ian Dumpert, and Christopher Chapdeline of Denver, Colorado, and Kasey Greenwald of Evergreen, Colorado.  The applicant/assignee is Green Brands, LLC.  This patent is a plant patent under 35 U.S.C. §161, which protects …

Continue Reading

Fed Circuit Watch: No State Sovereign Immunity in IPR

AIA fed circuit watch IPR patent sovereign immunity

On June 14, 2019, the Court of Appeals for the Federal Circuit delivered its long-awaited opinion on state sovereign immunity in post-grant proceedings in Regents of the Univ. of Minnesota v. LSI Corporation.[1]  Like it ruled in the sister case last year, Saint Regis Mohawk Tribe v. Mylan Pharms. Inc.,[2] dealing with tribal sovereign immunity, …

Continue Reading

CannabIP: U.S. Patent No. 10,265,362 B2

Cannabis IP patent

U.S. Patent No. 10,265,362 B2 (‘362) issued on April 23, 2019, for “Ingestible Films Having Substances From Hemp or Cannabis.”  It was issued to applicant/inventor Scott Schaneville, of St. Petersburg, Florida. Figure 1-2 illustrates the claimed invention: The ‘362 patent discloses a new system for cannabis medical drug delivery, specifically through mucosal oral administration of …

Continue Reading

CannabIP: Second Circuit Refuses to Dismiss CBD Reclassification Case

Cannabis IP patent trademark

On May 30, 2019, the Court of Appeals for the Second Circuit in Washington v. Barr,[1] refused to dismiss outright a case where the plaintiffs alleged marijuana’s classification on the Drug Enforcement Agency (DEA)’s Schedule I list of the Controlled Substance Act (CSA) of the poses a “serious, life-of-death threat to their health.”  The Second …

Continue Reading

TechPat: Justice Department Reviews Truvada Manufacturer for Possible Patent Violations

patent Tech Patents

The U.S. Department of Justice (DOJ) has recently opened an investigation into possible violations of Gilead Sciences, Inc.’s exclusive license with the U.S. Government of its blockbuster HIV drug, TRUVADA®.  Truvada is the pre-exposure prophylaxis (PrEP) which has been shown to prevent HIV infections.  Because of its exclusive license, Gilead is the only manufacturer of …

Continue Reading

CannabIP: U.S. Patent No. 10,179,694 B2

Cannabis IP patent

U.S. Patent No. 10,179,694 B2 (‘694) issued on November 20, 2018, for “Constant Illuminated Tamper-Resistant Plant Shipping Container.”  It was issued to applicant/inventor Larry D. Fenner, Jr. of Bellingham, Washington.  The assignee is THC Acquisition Corp. of Kelowna, British Columbia.  THC BioMed Ltd. is the parent company, a Canadian medical cannabis company. Figure 1 illustrates …

Continue Reading